Literature DB >> 21109292

Effect of Serenoa repens, lycopene, and selenium on proinflammatory phenotype activation: an in vitro and in vivo comparison study.

Giulio Bonvissuto1, Letteria Minutoli, Giuseppe Morgia, Alessandra Bitto, Francesca Polito, Natasha Irrera, Herbert Marini, Francesco Squadrito, Domenica Altavilla.   

Abstract

OBJECTIVES: To investigate the antiinflammatory activity of Serenoa repens (SeR), LY, and) on proinflammatory phenotype in rat peritoneal macrophages (Ms) stimulated with Salmonella enteritidis lipopolysaccharide (LPS) and in the prostate of rats with partial bladder outlet obstruction. SeR, combined with other compounds, such as LY and Se is used to relieve symptoms associated with benign prostatic hyperplasia (BPH). Inflammation plays a pivotal role in the pathogenesis of BPH and represents a target for anti-BPH drugs.
METHODS: After stimulation with 1 μg/mL of LPS, peritoneal rat MΦs were coincubated with LY (2 μg/mL), Se (0.03 μg/mL), and SeR (10 μg/mL), alone or in association (LY-Se-SeR) and with RPMI. Inducible cyclooxygenase (COX-2), 5-lypoxygenase (5-LOX), inducible nitric oxide synthase (iNOS), and inhibitor κBα (IκB-α) protein were evaluated by Western blot. Nuclear factor-kappa B (NF-κB) binding activity was measured by electrophoretic mobility shift assay. Tumor necrosis factor-α (TNF-α) gene expression was investigated by real-time polymerase chain reaction. We also evaluated malondialdehyde (MDA) and nitrite levels.
RESULTS: LPS stimulation produced a proinflammatory phenotype in rat peritoneal MΦs. LY, Se, and SeR inhibited the inflammatory cascade, but the Ly-Se-SeR association caused a greater inhibitory effect on the expression of COX-2, 5-LOX, and iNOS. The Ly-Se-SeR association showed a higher efficacy in reducing the loss of IκB-α, the increased NF-κB binding activity, the enhanced mRNA levels of TNF-α, the elevated MDA, and nitrite content. The LY-Se-SeR association in vivo caused a greater inhibitory effect on prostate inflammation induced in rats by partial bladder outlet obstruction.
CONCLUSIONS: The LY-Se-SeR association might be useful in the treatment of BPH. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21109292     DOI: 10.1016/j.urology.2010.07.514

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

Review 1.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

2.  Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene.

Authors:  Letteria Minutoli; Domenica Altavilla; Herbert Marini; Mariagrazia Rinaldi; Natasha Irrera; Gabriele Pizzino; Alessandra Bitto; Salvatore Arena; Sebastiano Cimino; Francesco Squadrito; Giorgio Ivan Russo; Giuseppe Morgia
Journal:  J Biomed Sci       Date:  2014-03-10       Impact factor: 8.410

3.  The evaluation of protective effect of lycopene against genotoxic influence of X-irradiation in human blood lymphocytes.

Authors:  Aneta Gajowik; Małgorzata M Dobrzyńska
Journal:  Radiat Environ Biophys       Date:  2017-09-14       Impact factor: 1.925

4.  Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study.

Authors:  Giuseppe Morgia; Antonio Micali; Mariagrazia Rinaldi; Natasha Irrera; Herbert Marini; Domenico Puzzolo; Antonina Pisani; Salvatore Privitera; Giorgio I Russo; Sebastiano Cimino; Antonio Ieni; Vincenzo Trichilo; Domenica Altavilla; Francesco Squadrito; Letteria Minutoli
Journal:  Int J Mol Sci       Date:  2017-03-22       Impact factor: 5.923

Review 5.  Are We Sentenced to Pharmacotherapy? Promising Role of Lycopene and Vitamin A in Benign Urologic Conditions.

Authors:  Piotr Kutwin; Piotr Falkowski; Roman Łowicki; Magdalena Borowiecka-Kutwin; Tomasz Konecki
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

6.  Effect of αlipoic acid and silymarin on bladder outlet obstruction.

Authors:  Abidin Yildirim; Barbaros Başeskioğlu; Halide E Temel; Nilüfer Erkasap; Aydin Yenilmez; Sema Uslu; Caner Ozer; Mete Ozkurt; Turgut Dönmez
Journal:  Exp Ther Med       Date:  2012-11-23       Impact factor: 2.447

7.  Lipidosterolic extract of serenoa repens modulates the expression of inflammation related-genes in benign prostatic hyperplasia epithelial and stromal cells.

Authors:  Nanor Sirab; Grégoire Robert; Virginie Fasolo; Aurélien Descazeaud; Francis Vacherot; Alexandre de la Taille; Stéphane Terry
Journal:  Int J Mol Sci       Date:  2013-07-10       Impact factor: 5.923

Review 8.  Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia.

Authors:  Letteria Minutoli; Mariagrazia Rinaldi; Herbert Marini; Natasha Irrera; Giovanni Crea; Cesare Lorenzini; Domenico Puzzolo; Andrea Valenti; Antonina Pisani; Elena B Adamo; Domenica Altavilla; Francesco Squadrito; Antonio Micali
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

9.  Nutraceutical Effects of Lycopene in Experimental Varicocele: An "In Vivo" Model to Study Male Infertility.

Authors:  Pietro Antonuccio; Antonio Micali; Domenico Puzzolo; Carmelo Romeo; Giovanna Vermiglio; Violetta Squadrito; Jose Freni; Giovanni Pallio; Vincenzo Trichilo; Maria Righi; Natasha Irrera; Domenica Altavilla; Francesco Squadrito; Herbert R Marini; Letteria Minutoli
Journal:  Nutrients       Date:  2020-05-25       Impact factor: 5.717

10.  The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Kai Zhang; Run-Qi Guo; Shan-Wen Chen; Bin Chen; Xin-Bo Xue; Shan Chen; Jian Huang; Ming Liu; Ye Tian; Li Zuo; Ming Chen; Li-Qun Zhou
Journal:  World J Urol       Date:  2021-01-16       Impact factor: 4.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.